InStride announced a $30 million Series C funding round.
- Amount
- $30M
- Stage
- Series C
- Announced
- 2 July 2026
- Investors
- Echo Health Ventures, FMZ Ventures, .406 Ventures, Valtruis, General Catalyst, Mass General Brigham Ventures
- Use of funds
- The capital will fuel InStride's expansion into new markets while deepening access in existing ones.
- Checked
- Amount and date checked against the press source